This change will take effect December 15, 2015
Overview and Clinical Utility:
Effective December 15, 2015, the gene name Plasminogen Activator Inhibitor, Type 1 (PAI1) will change to Serpin Peptidase Inhibitor, Clade E, Member 1 (SERPINE1). The orderable test code, PAI, will not change, however PathGroup will update all applications and directories to reflect the revised test name and description outlined below. In addition, PathGroup will implement new test methodology by PCR followed by fragment length analysis.
Click Here to read more.